openPR Logo
Press release

Liquid Biopsy Market Predicted to Surpass US$ 5.8 billion by 2026 - Leading Key Players are F. Hoffmann-La Roche Ltd. (Switzerland), Myriad Genetics, Inc. (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Guardant Health, Inc. (US)

11-04-2022 08:37 AM CET | Health & Medicine

Press release from: MarketsandMakets

Liquid Biopsy Market

Liquid Biopsy Market

According to a Comprehensive Research Report by MarketsandMarkets Liquid Biopsy Market by Product (Assay Kits, Instruments, Service), Circulating Biomarkers (CTC, ctDNA), Technology (NGS, PCR), Application (Cancer (Lung, Breast, Prostate), Non-Cancer), End User (Reference Lab, Hospitals) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 5.8 billion by 2026 from USD 2.5 billion in 2021, at a CAGR of 18.1%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=13966350&utm_source=Openpr&utm_medium=referral

The rising incidence and prevalence of cancer and the increasing preference for noninvasive treatment procedures are among the major factors propelling the growth of this market. Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the market.

The assay kits segment accounted for the largest share of the liquid biopsy market, by product & service segment, in 2020

Based on product & service, the market is segmented into assay kits, instruments, and services. The assay kits segment accounted for the largest share of the liquid biopsy market in 2020. The standard purchase requirement of assay kits makes them a recurrent cost which is a key factor boosting the market growth of this segment.

Circulating tumor DNA (ctDNA) segment to register the highest growth rate during the forecast period

The liquid biopsy market is segmented into circulating tumor cells, circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVS), and other circulating biomarkers. The circulating tumor DNA (ctDNA) segment is expected to grow at the highest CAGR during the forecast period. The superiority of ctDNA to previous plasma biomarkers in sensitivity and clinical correlations is a major factor driving its growth.

The reference laboratories segment accounted for the largest share of the liquid biopsy, by end user segment, in 2020

Based on end users, the liquid biopsy market has been segmented into reference laboratories, hospitals and physician laboratories, academic & research centers, and other end users. In 2020, the reference laboratories segment accounted for the largest share of the market. The increasing outsourcing of liquid biopsy tests to reference laboratories is driving this segments growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=13966350&utm_source=Openpr&utm_medium=referral

North America is the largest regional market for liquid biopsy market

The global market has been segmented into four major regions North America, Europe, the Asia Pacific, and the Rest of the World. In 2020, North America accounted for the largest share of the market. The large share of this region can be attributed to the highly developed healthcare systems in the US and Canada, increasing prevalence of cancer, and presence of many leading national clinical laboratories.

The major players operating in this liquid biopsy market are F. Hoffmann-La Roche Ltd. (Switzerland), Myriad Genetics, Inc. (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Guardant Health, Inc. (US), MDxHealth SA (Belgium), Exact Sciences Corporation (US), Illumina Inc. (US), Sysmex Inostics (US), Bio-Rad Laboratories, Inc. (US), Biocept, Inc. (US), NeoGenomics, Inc. (US), ANGLE plc (UK), Menarini-Silicon Biosystems (Italy), Vortex Biosciences, Inc. (US), Exosome Diagnostics, Inc. (US), Agena Bioscience, Inc. (US), MedGenome Inc. (US), Epigenomics AG (Germany), and Personal Genome Diagnostics, Inc. (US).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=13966350&utm_source=Openpr&utm_medium=referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liquid Biopsy Market Predicted to Surpass US$ 5.8 billion by 2026 - Leading Key Players are F. Hoffmann-La Roche Ltd. (Switzerland), Myriad Genetics, Inc. (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Guardant Health, Inc. (US) here

News-ID: 2789662 • Views:

More Releases from MarketsandMakets

Warehouse Robotics Market Set to Grow at the Fastest Rate- Time to Grow your Revenue
Warehouse Robotics Market Set to Grow at the Fastest Rate- Time to Grow your Rev …
The warehouse robotics market is estimated to be worth USD 6.1 billion in 2023 and is projected to reach USD 10.5 billion by 2028, at a CAGR of 11.4% during the forecast period. The expansion of e-commerce industry driving significant revenue growth and rapid developments in robotics and artificial intelligence are major factors driving the global growth of the warehouse robotics market. Moreover, transformation of warehouses through the integration of
Global Vascular Patches Market Growth to Reach USD 517 million by 2027
Global Vascular Patches Market Growth to Reach USD 517 million by 2027
The global Vascular Patches Market is valued at an estimated USD 353 million in 2022 and is projected to reach USD 517 million by 2027, at a CAGR of 7.9% during the forecast period. Market growth is driven by the growing geriatric population and subsequent prevalence of vascular diseases and availability of reimbursement for vascular procedures, coupled with the growing adoption of biological patches. Key Market Players: LeMaitre Vascular, Inc. (US),
Mice Model Market Size, Share, Growth Rate, Demands, Trends, Key Players and Forecasts to 2029
Mice Model Market Size, Share, Growth Rate, Demands, Trends, Key Players and For …
The global Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying
Global Antibody Drug Conjugates Market Key Players are Daiichi Sankyo Company, Limited (Japan), Seagen Inc. (US), Gilead Sciences, Inc. (US) and Others
Global Antibody Drug Conjugates Market Key Players are Daiichi Sankyo Company, L …
The global Antibody Drug Conjugates Market in terms of revenue was estimated to be worth $9.7 billion in 2023 and is poised to reach $19.8 billion by 2028, growing at a CAGR of 15.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and

All 5 Releases


More Releases for MarketsandMarkets

Automotive Engineering Services Market | MarketsandMarkets
Automotive engineering services deal with the design and development of automotive components and related technologies to address complex technical challenges in the vehicle development value chain. The engineering service process starts with conceptualization, designing, prototyping, system integration, and testing. Automotive engineering services include vehicle connectivity services, ADAS (advanced driver-assistance systems) and safety systems, interior & exterior design and body engineering services, passenger comfort, and others. These services assess different areas
Automotive Cybersecurity Market Trends & Insights | MarketsandMarkets
According to the new market research report "Automotive Cybersecurity Market by Form (In-Vehicle, External Cloud Services), Offering (Hardware & Software), Security, Application Type, Vehicle Type, Propulsion, Vehicle Autonomy, Approach, EV Application, and Region - Global Forecast to 2026", Published by MarketsandMarkets™, The global Automotive Cybersecurity Market size is projected to grow from USD 2.0 billion in 2021 to USD 5.3 billion by 2026, at a CAGR of 21.3%. Increasing sales
Global Brake Friction Products Market | MarketsandMarkets
According to the new market research report "Brake Friction Products Market (OE & Aftermarket) by Type (Brake Disc, Pad, Drum, Shoe, Liner), Disc Type (Metallic, Composite, Ceramic), Liner Type (Molded, Woven), Vehicle Type (ICE, Electric, PHEV, OHV), and Region - Global Forecast to 2026", published by MarketsandMarkets™, The Brake Friction Products Market is projected to reach USD 13.3 billion by 2026 from USD 10.8 billion in 2021, at a CAGR
Global Electric Commercial Vehicle Market | MarketsandMarkets
The Global Electric Commercial Vehicle Market size is projected to reach 2,026 thousand units by 2028 from a projected 129 thousand units in 2020, at a CAGR of 41.1%. The electric commercial vehicle segment has witnessed rapid evolution with governments across the world promoting electrification of public transport fleets and with the increasing demand for zero-emission vehicles in the eCommerce and logistics sector. Advancements in battery pack technologies and electric powertrains
Global Automotive Glass Market | MarketsandMarkets
The Automotive Glass Market is projected to grow at a CAGR of 4.80%, to reach a market size of $23.59 billion by 2025. The global market is driven by increasing vehicle production (especially in the SUV segment), upcoming smart glass & device embedded glass technologies, and increasing glass applications to improve the aesthetics of the car. The key players in the automotive glass market are Saint-Gobain (France), Asahi Glass (Japan), Fuyao
Automotive Logistics Market | MarketsandMarkets
The Automotive Logistics Market is estimated to be $284.1 billion in 2018 and is projected to reach $472.9 billion by 2025, at a CAGR of 7.55%. Increasing vehicle production, upcoming infrastructure projects, and the advent of electric vehicles are the major reasons for market growth. The automotive logistics market is consolidated and dominated by a few global players. The key players in the market are DHL (Germany), XPO (US), SNCF (France),